After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Lexeo Therapeutics Inc is $152.70M. A total of 0.55 million shares were traded on the day, compared to an average of 819.85K shares.
In the most recent transaction, Townsend Richard Nolan sold 1,074 shares of LXEO for 2.77 per share on May 16 ’25. After the transaction, the Chief Executive Officer now owns 221,173 company shares. In a previous transaction on May 16 ’25, Adler Eric sold 585 shares at 2.77 per share. LXEO shares that Chief Medical Officer owns now total 67,681.
Among the insiders who sold shares, Robertson Jenny disposed of 521 shares on May 16 ’25 at a per-share price of $2.77. This resulted in the Chief Legal Officer holding 63,098 shares of LXEO after the transaction. In another insider transaction, See Tai Sandi sold 367 shares at $2.77 per share on May 16 ’25. Company shares held by the Chief Development Officer now total 59,242.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, LXEO has a high of $19.50 and a low of $1.45.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. LXEO’s latest balance sheet shows that the firm has $135.86M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $7.45M in liabilities at the time. Its Book Value Per Share was $2.65, while its Total Shareholder’s Equity was -$55.60M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LXEO is Buy with a score of 4.86.
